Cyclin-dependent kinase-inhibitor screening and structural analysis identify a CDK-like kinase candidate in Naegleria fowleri. [PDF]
Kim MJ, No JH.
europepmc +1 more source
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer Drug. [PDF]
Shimokawa K +24 more
europepmc +1 more source
Emerging Strategies to Inhibit the G1/S Transition for Cancer Therapy. [PDF]
Rubin SM, Sage J, Skotheim JM.
europepmc +1 more source
Cip/Kip proteins: more than just CDKs inhibitors.
C. Denicourt, S. Dowdy
semanticscholar +1 more source
PROTACs for Collateral Degradation: Is It Time to Back Up the Bus? [PDF]
Gao ZG, Burgess K.
europepmc +1 more source
Design, Synthesis, and Biological Evaluation of Selective CDK4/9 Inhibitors. [PDF]
Li S +6 more
europepmc +1 more source
MNAT1 in gastrointestinal cancers: mechanistic insights and therapeutic strategies-a narrative review. [PDF]
Zhang Y +5 more
europepmc +1 more source
Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
David Santamaría, Sagrario Ortega
semanticscholar +1 more source
RNA polymerase II phosphorylation dynamics: from molecular mechanisms to human disease. [PDF]
González-Jiménez A +4 more
europepmc +1 more source

